Brain Navi Announces 100th Surgical Procedure Completed Using NaoTrac streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Brain Navi, the leading surgical robot manufacture in Taiwan, announced a strategic partnership with distributor, Medtreq Medical Equipment, to.
/PRNewswire/ NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from Taiwan s Food and Drug Administration (TFDA) in July 2022, and.
HSINCHU, Aug. 8, 2022 /PRNewswire/ NaoTrac, the CE-certified neurosurgical navigation robot, achieved approval from the local government of the Ministry of Health and Welfare in Taiwan in July 2022 and is planned for submission to the FDA (U.S. Food and Drug Administration) for clearance by the end of 2022. The NaoTrac human trials were performed at the reputable Hualien Tzu-Chi Medical Center, with the External Ventricular Drain (EVD) placement abstract results published in the well-known European journal Acta Neurochirurgica. Dr. Tsung-Lang, Chiu stated, "The results of this report show that the average time spent on the patient registration was 1423.8 seconds. The mean target deviation was 1.68mm, and the mean angular deviation was 1.99 degrees, all within the accepted tolerance for minimal tissue damage." Dr. Chiu concluded, "NaoTrac has several advantages besides the high precision, like a non-invasive, non-contact patient registration process with a fast and accu
/PRNewswire/ Brain Navi Biotechnology, a Taiwan-based startup specializing in innovative navigation robots, received CE mark approval for brain surgery.